June 28, 2016 – BIOX Corporation and World Energy have announced a 50/50 joint venture to acquire and operate a 341 million litre (90 million U.S. gallon, or USG) biodiesel production facility in Houston, Texas.
By Brandi Cowen
Each company has committed $10 million US to the World Energy BIOX Biofuels joint venture.
The facility, formerly known as Green Earth Fuels, is located within the Kinder Morgan Liquids terminal on the Houston Ship Channel and is the third largest biodiesel production facility in North America. The plant acquisition is scheduled to close by the end of June.
Plant commissioning and start-up will ramp up over the third quarter of the year.
“This joint venture with World Energy and the acquisition of a 90 million USG facility provide BIOX an opportunity to significantly expand and diversify our production capacity in combination with a high quality partner. It is a large scale asset that is well positioned to supply biodiesel for compliance with the Federal Renewable Fuel Standard in the U.S. market,” said Alan Rickard, chief executive officer of BIOX. “As we see the distribution of our products from our facilities in Ontario shifting from the U.S. market to fulfill the mandates under Ontario’s Greener Diesel initiative, this acquisition provides us with a strategically positioned production facility from which we can address the U.S. market in partnership with World Energy. World Energy’s approach to sales and marketing is aligned with ours, as trusted producers and marketers that leverage their expertise, experience and relationships in the industry to provide optimal value to clients.”
“World Energy and BIOX have been biodiesel industry pioneers dating from the very beginnings of the industry,” said Gene Gebolys, chief executive officer of World Energy. “This venture enables us to lever our collective strengths to serve customers better than ever before with unparalleled logistical access by rail, truck, barge, ship, and pipeline to the biggest biofuels markets in the U.S. and beyond.”
In order to fund its $10 million US contribution to the joint venture, BIOX has secured a funding commitment from a group of its existing shareholders: Clearwater Fine Foods Inc. (CFFI), T. Robert Beamish and William Lambert, with CFFI, Beamish and Lambert being referred to collectively as the “private placees.” Beamish and Lambert are also directors of BIOX.
CFFI will provide a six month, secured bridge loan for $5 million US. In addition, the private placees will subscribe for 5,000 units of BIOX for gross proceeds of $5 million US (the “private placement”), with each unit consisting of a secured note in the principal amount of $1,000 US (collectively, the “notes”) and 880 common share purchase warrants (“warrants”) exercisable at a price of $0.673 per common share (being 125 per cent of the volume weighted average trading price for the common shares of BIOX on the Toronto Stock Exchange for the five-day period ended on June 24). The bridge loan and the private placement were approved by the independent members of the board. Material terms of these financings are as follows:
- Both the bridge loan and the notes provide for voluntary prepayments without premium or penalty.
- Neither the bridge loan nor the notes are convertible, directly or indirectly, into equity or voting securities of BIOX or any of its subsidiaries, or otherwise participating in nature; or repayable as to principal or interest, directly or indirectly, in equity or voting securities of BIOX or any of its subsidiaries.
- The bridge loan and the notes will be secured by a pledge of the interest held by a wholly-owned subsidiary of BIOX in the joint venture company formed to complete the acquisition of the Houston facility.
- The notes will have an initial six-month term that will be automatically extended to June 30, 2018, if shareholders approve the warrants as discussed below.
- The bridge loan will bear interest at a rate of 12 per cent per annum from the date of advance to Aug. 31, at 14 per cent from Sept. 1 to 30, at 16 per cent from Oct. 1 to 31, and at 18 per cent thereafter, payable monthly in arrears.
- The notes will bear interest at a rate of 12 per cent per annum payable quarterly in arrears.
BIOX will convene a special meeting of shareholders to be held not later than Dec. 31 to seek approval of the warrants by shareholders other than the private placees. Until this dis-interested shareholder approval is obtained, the warrants are not transferable or exercisable. If the warrants are not approved, then:
- The warrants will terminate automatically.
- BIOX will be obligated to pay an exit fee at the time the bridge loan is repaid in an amount equal to two per cent of the face amount thereof if paid on or before Sept. 30 or 3.5 per cent of the face amount thereof if the bridge loan is repaid after Sept. 30.
- BIOX will be obligated to pay an exit fee at the time the notes are repaid in an amount equal to two per cent of the face amount thereof if paid on or before Sept. 30 or five per cent of the face amount thereof if the bridge loan is repaid after Sept. 30.
BIOX board of directors changes
With the establishment of the World Energy BIOX joint venture, the board of directors of BIOX has accepted the request of Robert Beamish to retire from the board. To fill the vacancy created by Beamish’s retirement, the board has appointed Gene Gebolys, CEO of World Energy, effective as of the closing of the transaction. In addition, the board of directors has determined that it is an appropriate time to appoint Alan Rickard, CEO of BIOX, to the board of directors.
“Mr. Beamish has provided a tremendous amount of experience and valuable advice as a member of the board during the past nine years. On behalf of everyone at BIOX, I would like to thank him for his service,” said Kevin Golding, chair of BIOX. “With this first direct investment in the U.S. market, the board concluded that Mr. Gebolys’ unique perspective on the U.S. market would provide invaluable insight to the board, while helping to unify the strategic direction of the joint venture with BIOX’s plan for growth. Gene and Alan bring a great deal of industry experience from both a market and operations perspective.”
Since 1996, Gebolys has championed biodiesel’s development in the U.S. and throughout the world. He founded World Energy in 1998, which emerged to become an enduring and innovative force in the advanced biofuels industry over two decades. He was the founding chairman of the National Biodiesel Political Action Committee and was a founding commissioner of the National Biodiesel Accreditation Commission (BQ-9000). He was chair of the National Biodiesel Board’s Regulatory Committee for five years during the establishment of the industry’s most critical public policy supports, including the establishment of the Biodiesel Blenders Tax Credit and both Federal Renewable Fuels Standards (RFS1 and RFS2). He now co-chairs the industry’s RFS Task Force, which he has chaired since its inception in 2009.
Rickard has served as chief executive officer of BIOX since October 2015. Rickard has more than 15 years of experience in the agri-food, energy and renewable fuels sectors. Prior to joining BIOX he served as vice-president of commercial operations, Canada, at Rothsay, a division of Darling International Canada Inc., and previously at Maple Leaf Foods Inc. in increasingly senior positions between 2001 and 2013.
About World Energy
World Energy (www.worldenergy.net) is an advanced biofuels supplier based in Boston with over 200 million gallons (600,000 metric tons) of production capacity in Pennsylvania, Georgia, Mississippi, and Texas, and over 16 million gallons of biofuels storage servicing major markets in North America and beyond.
About BIOX Corporation
BIOX is a renewable energy company that owns and operates approximately 450 million litres of nameplate biodiesel production capacity at plants located in southern Ontario and Houston. BIOX has an innovative, proprietary and patented production process that is capable of producing high quality, renewable, clean burning and biodegradable biodiesel fuel utilizing a variety of feedstocks, from pure seed oils to animal fats to recovered vegetable oils, with no change to the production process. BIOX’s high quality biodiesel fuel meets North American (ASTM D-6751) quality standards.
Certain statements in this press release constitute “forward-looking” statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of BIOX, or industry results, to be materially different from any future results, performance, objectives or achievements expressed or implied by such forward-looking statements. Such statements relate to, among other things, the timeline for the World Energy BIOX Biofuels facility commencing production, the capacity of and anticipated upgrades to the facility and timing thereof, improvements to the facility’s efficiency and range of feedstocks it will be able to use, anticipated production capacity increase from the acquisition, BIOX’s long-term expectations for the biodiesel market in light of current market conditions, and the ability of BIOX to benefit from recent regulatory initiatives in the U.S. and Ontario and the satisfaction of all conditions of closing for the acquisition and the financing. These statements reflect BIOX’s current views regarding future events and operating performance, are based on information currently available to BIOX, and speak only as of the date of this press release. These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks include, but are not limited to, the fact that BIOX’s results of operations and business outlook are highly dependent on a mix of legislation and producer payment programs and tax credits and upon commodity prices, which are subject to significant volatility and uncertainty. Many factors could cause the actual results, performance or achievements of BIOX to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including factors described in this press release and those discussed in BIOX’s publicly available disclosure documents, as filed by BIOX on SEDAR (www.sedar.com) except as updated herein. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described in this press release as intended, planned, anticipated, believed, estimated or expected. Unless required by applicable securities law, BIOX does not intend and does not assume any obligation to update these forward-looking statements. To the extent any forward-looking statements herein constitute financial outlook, they were approved by management as of the date hereof and have been included to provide an understanding with respect to BIOX’s financial performance and are subject to the same risks and assumptions referred to herein. There can be no assurance that the plans, intentions or expectations upon which these forward-looking statements are based will occur and readers are cautioned that any financial outlook information contained in this news release should not be used for purposes other than for which it is disclosed herein.
Source: BIOX Corporation